透過您的圖書館登入
IP:18.219.213.196
  • 期刊
  • OpenAccess

Proinflammatory Cytokines Inhibit Expression of Erythropoietin Receptor Messenger Ribonucleic Acid

並列摘要


BACKGROUND: Higher serum cytokine levels were shown to be accompanied with anemia in patients with chronic inflammatory diseases. The influence of proinflammatory cytokines on erythropoietin receptor (EpoR) messenger ribonucleic acid (mRNA) expression was investigated in this study.METHODS: Human erythroleukemia cells, TF-1 (5 x 10^6 cells/mL), were incubated with serial dilutions of interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α). The expression of EpoR mRNA in TF-1 cells was measured.RESULTS: EpoR mRNA transcripts in TF-1 cells were inhibited by all three cytokines in a concentration-dependent manner. The percentage of inhibition increased with treatment duration; with the maximal inhibition appearing after 16 hours of treatment. EpoR mRNA transcripts in TF-1 cells were inhibited by 44.2 ± 1.7% with IL-6 and 49.1 ± 3.8% with TNF-α after 16-hour incubation with 200 units/mL of individual cytokine.CONCLUSION: The obtained results showed that proinflammatory cytokine-induced decrease of EpoR in erythroid progenitor cells may be one of the major causes of anemia in patients with chronic kidney and inflammatory diseases.

參考文獻


Chateauvieux S, Grigorakaki C, Morceau F, Dicato M, Diederich M. Erythropoietin, erythropoiesis and beyond. Biochem Pharmacol 82: 1291-1303, 2011.
Watowich SS. The erythropoietin receptor: molecular structure and hematopoietic signaling pathways. J Invest Med59: 1067-1072, 2011.
Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis44: 94-111, 2004.
Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, et al. Anaemia in haemodialysis patients of five European coun-tries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant19:121-132, 2004.
Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent-resistant anemia in dialysis pa-tients: review of causes and management. Blood Purif29: 1-12, 2010.

延伸閱讀